Syros Pharmaceuticals (SYRS) Q4 2023 Earnings

27MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.18
-1.74
-1.29
-0.85

Details

Expected EPS
-1.14
Actual EPS
-2.18
Surprise EPS
-1.04
Surprise Percent
+91.23%

Description

Syros Pharmaceuticals (SYRS) has reported earnings of -2.18 per share for Q4 2023.

0 Comments

Share your thoughts